Founded by Richard Ferrari in the United States, Saratoga Ventures primarily invests in biotechnology and pharmaceutical startups. With a preference for founders aged 6-10 years, the fund typically invests in rounds with 4-5 participants, ranging from $10-50 million. While the fund has a lower exit rate compared to other organizations, it has had successful investments in companies like Broncus Technologies and Tibion Bionic Technologies. The team at Saratoga Ventures brings together expertise in medical devices, venture finance, and business development, which has contributed to their success in finding new opportunities and making investment decisions.